2014 annual financial data

Corcept Therapeutics 2014 Net margin

Corcept Therapeutics 2014 net margin with verified reported values.

Direct answer

Net margin was -118.2%.

Operating income was -27,619,000 USD and net income was -31,383,000 USD.
Operating cash flow was -27,376,000 USD.

Get free Corcept Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
26,551,000 USD
Operating income
-27,619,000 USD
Net income
-31,383,000 USD
Operating cash flow
-27,376,000 USD